PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $0 | -100.0% | 13,190 | 0.0% | 0.00% | – |
| Q4 2020 | $32,579,000 | -68.3% | 13,190 | -59.5% | 0.00% | – |
| Q3 2020 | $102,630,000 | +149.3% | 32,581 | +130.3% | 0.00% | – |
| Q2 2020 | $41,174,000 | -61.1% | 14,149 | -62.3% | 0.00% | – |
| Q1 2020 | $105,713,000 | +35.8% | 37,487 | +56.3% | 0.00% | – |
| Q4 2019 | $77,835,000 | +40.3% | 23,986 | -6.6% | 0.00% | – |
| Q3 2019 | $55,473,000 | -11.2% | 25,682 | +29.2% | 0.00% | – |
| Q2 2019 | $62,436,000 | -50.9% | 19,884 | -41.9% | 0.00% | – |
| Q1 2019 | $127,243,000 | +903.8% | 34,205 | +682.5% | 0.00% | – |
| Q4 2018 | $12,676,000 | -50.1% | 4,371 | -54.8% | 0.00% | – |
| Q3 2018 | $25,424,000 | +3.5% | 9,667 | -7.9% | 0.00% | – |
| Q2 2018 | $24,561,000 | -80.6% | 10,496 | -75.6% | 0.00% | – |
| Q1 2018 | $126,641,000 | -33.9% | 43,075 | -38.4% | 0.00% | – |
| Q4 2017 | $191,518,000 | +5.4% | 69,897 | +30.4% | 0.00% | – |
| Q3 2017 | $181,650,000 | +231.8% | 53,584 | +141.7% | 0.00% | – |
| Q2 2017 | $54,750,000 | +554.0% | 22,166 | +501.0% | 0.00% | – |
| Q1 2017 | $8,372,000 | -60.6% | 3,688 | -63.2% | 0.00% | – |
| Q4 2016 | $21,274,000 | -64.6% | 10,035 | -44.1% | 0.00% | – |
| Q3 2016 | $60,179,000 | +85.6% | 17,964 | +74.0% | 0.00% | – |
| Q2 2016 | $32,424,000 | +2690.4% | 10,326 | +2858.7% | 0.00% | – |
| Q1 2016 | $1,162,000 | -99.1% | 349 | -99.1% | 0.00% | – |
| Q4 2015 | $130,569,000 | -84.1% | 36,884 | -77.4% | 0.00% | -100.0% |
| Q3 2015 | $820,982,000 | +4.2% | 163,217 | +33.2% | 0.00% | 0.0% |
| Q2 2015 | $787,610,000 | +1812.4% | 122,490 | +1993.8% | 0.00% | – |
| Q1 2015 | $41,184,000 | -98.5% | 5,850 | -98.3% | 0.00% | -100.0% |
| Q4 2014 | $2,702,656,000 | +27.6% | 350,539 | +23.6% | 0.01% | +400.0% |
| Q3 2014 | $2,117,700,000 | -59.7% | 283,494 | -47.7% | 0.00% | -60.0% |
| Q2 2014 | $5,248,535,000 | +77.7% | 542,204 | +55.8% | 0.01% | +150.0% |
| Q1 2014 | $2,954,220,000 | -8.7% | 347,965 | -9.3% | 0.00% | +100.0% |
| Q4 2013 | $3,236,860,000 | +115.8% | 383,514 | +103.8% | 0.00% | 0.0% |
| Q3 2013 | $1,500,060,000 | +13.5% | 188,213 | +10.0% | 0.00% | 0.0% |
| Q2 2013 | $1,321,180,000 | – | 171,137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |